AMPOLLINI, Luca
 Distribuzione geografica
Continente #
EU - Europa 11.775
NA - Nord America 10.537
AS - Asia 9.406
SA - Sud America 1.217
AF - Africa 469
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 33.422
Nazione #
US - Stati Uniti d'America 10.293
IT - Italia 6.272
SG - Singapore 3.333
CN - Cina 2.598
VN - Vietnam 1.289
IE - Irlanda 1.074
BR - Brasile 938
SE - Svezia 813
FR - Francia 803
FI - Finlandia 766
HK - Hong Kong 738
DE - Germania 520
NL - Olanda 436
BD - Bangladesh 401
ZA - Sudafrica 345
TR - Turchia 305
UA - Ucraina 283
GB - Regno Unito 238
IN - India 184
CA - Canada 129
AR - Argentina 116
RU - Federazione Russa 110
AT - Austria 86
MX - Messico 72
ES - Italia 70
IQ - Iraq 69
BE - Belgio 59
JP - Giappone 53
PL - Polonia 49
PH - Filippine 48
PK - Pakistan 46
KR - Corea 44
CH - Svizzera 40
EC - Ecuador 40
CZ - Repubblica Ceca 38
TH - Thailandia 35
CO - Colombia 33
ID - Indonesia 33
UZ - Uzbekistan 31
VE - Venezuela 28
MA - Marocco 21
CI - Costa d'Avorio 20
CL - Cile 20
LT - Lituania 20
EG - Egitto 19
IR - Iran 19
SA - Arabia Saudita 19
MY - Malesia 18
KE - Kenya 17
JO - Giordania 16
TW - Taiwan 16
DK - Danimarca 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
PE - Perù 14
AZ - Azerbaigian 13
IL - Israele 13
PY - Paraguay 12
RO - Romania 12
UY - Uruguay 10
NP - Nepal 9
OM - Oman 9
AU - Australia 8
GR - Grecia 8
HN - Honduras 8
JM - Giamaica 8
BG - Bulgaria 7
AL - Albania 6
BO - Bolivia 6
DZ - Algeria 6
LB - Libano 6
PT - Portogallo 6
SI - Slovenia 6
SN - Senegal 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
EU - Europa 5
RS - Serbia 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BY - Bielorussia 4
CR - Costa Rica 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NG - Nigeria 4
PA - Panama 4
BN - Brunei Darussalam 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
AM - Armenia 2
BB - Barbados 2
BT - Bhutan 2
Totale 33.388
Città #
Singapore 1.629
Ashburn 1.242
Chandler 1.199
Dublin 1.071
San Jose 948
Beijing 709
Hong Kong 693
Santa Clara 595
Dallas 516
Milan 411
Ho Chi Minh City 396
Rome 361
Ann Arbor 351
New York 346
Boardman 337
Dearborn 326
Johannesburg 325
Hanoi 309
Parma 291
Izmir 253
Nanjing 253
Jacksonville 211
Los Angeles 209
Lauterbourg 207
Princeton 205
Shanghai 180
Munich 138
Bologna 126
Wilmington 120
Naples 113
Hefei 104
Chicago 102
Helsinki 100
San Mateo 95
Jinan 92
Buffalo 90
Seattle 88
Turin 81
Shenyang 79
São Paulo 79
Kunming 76
Bremen 75
Columbus 75
Nanchang 66
Vienna 64
Council Bluffs 63
Guangzhou 62
Hebei 58
Florence 57
Brussels 52
Toronto 52
Catania 51
Haiphong 51
Moscow 50
Genoa 48
Des Moines 46
Palermo 46
Da Nang 45
Jiaxing 44
Frankfurt am Main 43
Houston 43
Padova 43
Tianjin 41
Bari 40
London 40
Rio Saliceto 40
Napoli 39
Changsha 37
Tokyo 37
The Dalles 36
Seoul 34
Turku 34
Chennai 33
Warsaw 33
Fremont 32
Brescia 31
Orem 31
Perugia 31
Modena 30
Brooklyn 29
Genova 29
Belo Horizonte 28
Tashkent 28
Nuremberg 27
Woodbridge 27
Atlanta 26
Reggio Emilia 26
Rio de Janeiro 26
Düsseldorf 25
Norwalk 25
Zhengzhou 25
Denver 24
Amsterdam 23
Baghdad 22
Hải Dương 22
Monza 22
Pisa 22
Mexico City 21
Stockholm 21
Abidjan 20
Totale 17.307
Nome #
EVOLUZIONE ATIPICA DI UN CASO DI LEIOMIOMA METASTATIZZANTE BENIGNO POLMONARE 2.524
TUMORE FIBROSO SOLITARIO MALIGNO DELLA PLEURA ASSOCIATO A SEVERA IPOGLICEMIA: LA SINDROME DI DOEGE-POTTER 1.896
Aerostasi in chirurgia toracica nell’Azienda Ospedaliero-Universitaria di Parma: introduzione nella pratica clinica del Tachosil, un sigillante registrato come farmaco 1.134
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 639
Diverticolo tracheale acquisito: una rara causa di emottisi 470
LIPOSARCOMA DEDIFERRENZIATO MEDIASTINICO GIGANTE: UN RISCONTRO ESTREMAMENTE RARO 293
A comparison between the effects of over-expression of miRNA-16 and miRNA-34a on cell cycle progression of mesothelioma cell lines and on their cisplatin sensitivity 265
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 261
Hydrogen sulfide inhibits tmprss2 in human airway epithelial cells: Implications for sars‐cov‐2 infection 244
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 234
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 232
Fistola tracheo-esofagea congenita di tipo “H” nell’adulto 226
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 213
Adenocarcinoma associato a melanoma amelanotico primario dell’esofago distale 206
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 205
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 204
227P Sexual dimorphism in immune profile of early and advanced NSCLC 202
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 197
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 194
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 194
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 193
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 192
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 191
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 182
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 182
Leiomioma metastatizzante benigno gigante 180
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 178
Antitumoral effect of a nanotechnology-based photodynamic therapy. 176
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 173
Intraoperative Endobronchial swab after major lung resection: does it influence the course of postoperative pulmonary infections ? 171
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 171
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 171
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 170
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 169
Lung metastasis resection of adenoid cystic carcinoma of salivary glands 168
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 167
CARCINOMA NEUROENDOCRINO PRIMITIVO DEL MEDIASTINO 166
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 165
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 163
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 162
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 161
Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study 160
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 160
Linezolid-induced black hairy tongue 159
Neoplasie del polmone in Neoplasie del Distretto Toracico 159
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) 158
IASLC and WHO 2004 Grading System as Prognostic Factors in 492 Cases of Pulmonary Adenocarcinoma 156
Isolation and characterization of human lung lymphatic endothelial cells 156
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 156
Cardiac autonomic and cortisol stress responses to real operations in surgeons: relationship with individual psychobiological characteristics and experience 153
A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery 153
Lipoma endobronchiale: una rara causa di ostruzione bronchiale 153
MEDIASTINITE FIBROSANTE ASSOCIATA A GRNULOMATOSI DI WEGENER 152
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 152
Delaying surgery for patients with a previous SARS-CoV-2 infection 152
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 151
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids 151
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 151
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 150
Posterior mediastinal myelolipoma resected by video-assisted thoracic surgery 149
Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry 148
Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. 148
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 148
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 147
Multiple primary malignancies involving lung cancer: a single-center experience 147
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 147
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 146
Physico-chemical characterization and biological evaluation of two fibroin materials 145
A novel method of tracheoesophageal fistula closure 144
A huge ulcerated mass of the thorax 141
Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: A European Society of Thoracic Surgeons Thymic Working Group Study 140
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 139
Abdominal visceral hernia through a chest wall defect secondary to open-window thoracostomy 138
Exercise capacity assessment in patients undergoing lung resection 138
Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on ct: Relation to clinical metrics 137
The Overweight Paradox: Impact of Body Mass Index on Patients Undergoing VATS Lobectomy or Segmentectomy 136
The value of lung metastases resection from adenoid cystic carcinoma 136
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer 135
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 135
microRNAs Expression in Malignant Pleural Mesothelioma, Asbestosis and Benign Pulmonary Disease 135
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 135
Metaplastic carcinoma spindle-cell type of the breast 134
Long-lasting tuberculous pleurisy 134
Cardiac tanponade in patient vith thoraco-abdominal aortic aneurysm 133
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. 133
Chirurgia per carcinoma mammario con modalità day- o one-day surgery: un’esperienza di 12 anni 133
Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: Results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database 133
Ground glass nodules evolution according with an history of tumour 132
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 132
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 131
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 131
An unusual case of thoracic calcifyng fibrous pseudotumor 131
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 131
Metastasectomia polmonare secondaria a tumore renale (RCC). Esperienza di Parma 130
METACHRONOUS AND SYNCHRONOUS OCCURRENCE OF PRIMARY MALIGNANCIES IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE OBSERVATIONAL STUDY 129
Insolita evoluzione della cavità pleurica dopo pneumonectomia destra 128
Multicenter experience of resected thymic epithelial tumors (TETs): an observational report on behalf of FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) 128
Primary Pulmonary Large Cell Carcinoma with Syncytiotrophoblastic Aspect: Report of a Case 128
Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax. 128
Placental Transmogrification of the Lung Presenting as a Giant Bulla Associated with a Pulmonary Hamartoma 127
Totale 22.066
Categoria #
all - tutte 105.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 0 0 0 105
2021/20221.436 85 72 92 104 51 60 158 132 91 114 63 414
2022/20234.819 422 518 282 366 375 554 142 351 1.367 70 264 108
2023/20242.534 179 223 101 94 198 471 195 195 148 175 195 360
2024/20255.736 177 344 400 302 579 554 274 249 798 532 543 984
2025/202611.746 1.119 974 1.354 944 1.581 655 1.264 488 1.419 844 650 454
Totale 33.757